 | • レポートコード：QFJ1-4387 • 出版社/出版日：QYResearch / 2021年6月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、105ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査レポートでは、腹腔内感染症治療薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（クロラムフェニコール、ベータラクタム、キノロン、アミノグリコシド、その他）、用途別市場規模（腹腔内膿瘍、虫垂炎、憩室炎、下痢、食中毒、ヘリコバクターピロリ感染症）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。 ・市場概要 ・腹腔内感染症治療薬の市場動向 ・企業の競争状況、市場シェア ・腹腔内感染症治療薬の種類別市場規模と予測2016-2027（クロラムフェニコール、ベータラクタム、キノロン、アミノグリコシド、その他） ・腹腔内感染症治療薬の用途別市場規模と予測2016-2027（腹腔内膿瘍、虫垂炎、憩室炎、下痢、食中毒、ヘリコバクターピロリ感染症） ・腹腔内感染症治療薬の北米市場規模2016-2027（アメリカ、カナダ） ・腹腔内感染症治療薬の欧州市場規模2016-2027（ドイツ、フランス、イギリス等） ・腹腔内感染症治療薬のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・腹腔内感染症治療薬の中南米市場規模2016-2027（メキシコ、ブラジル） ・腹腔内感染症治療薬の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（AstraZeneca、Merck、Pfizer、AtoxBio、Dainippon Sumitomo Pharma、Bayer、Bristol-Myers Squibb、Mylan Pharmaceuticals Inc.、Sun Pharmaceutical Industries, Inc.、Teva Pharmaceutical Industries、Dr. Reddy’s Laboratories、Roche Holding AG、GlaxoSmithKline、Sanofi） ・結論 |
Market Analysis and Insights: Global Intra-abdominal Infection Treatment Drugs Market
The global Intra-abdominal Infection Treatment Drugs market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Intra-abdominal Infection Treatment Drugs market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Intra-abdominal Infection Treatment Drugs market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Intra-abdominal Infection Treatment Drugs market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Intra-abdominal Infection Treatment Drugs market.
Global Intra-abdominal Infection Treatment Drugs Scope and Market Size
Intra-abdominal Infection Treatment Drugs market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Intra-abdominal Infection Treatment Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Chloramphenicol
Beta Lactums
Quinolones
Aminoglycosides
Others
Segment by Application
Intra-abdominal Abscess
Appendicitis
Diverticulitis
Diarrhea
Food Poisoning
Infection by Helicobacter Pylori
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
AstraZeneca
Merck
Pfizer
AtoxBio
Dainippon Sumitomo Pharma
Bayer
Bristol-Myers Squibb
Mylan Pharmaceuticals Inc.
Sun Pharmaceutical Industries, Inc.
Teva Pharmaceutical Industries
Dr. Reddy’s Laboratories
Roche Holding AG
GlaxoSmithKline
Sanofi
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Intra-abdominal Infection Treatment Drugs Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Chloramphenicol
1.2.3 Beta Lactums
1.2.4 Quinolones
1.2.5 Aminoglycosides
1.2.6 Others
1.3 Market by Application
1.3.1 Global Intra-abdominal Infection Treatment Drugs Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Intra-abdominal Abscess
1.3.3 Appendicitis
1.3.4 Diverticulitis
1.3.5 Diarrhea
1.3.6 Food Poisoning
1.3.7 Infection by Helicobacter Pylori
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Intra-abdominal Infection Treatment Drugs Market Perspective (2016-2027)
2.2 Intra-abdominal Infection Treatment Drugs Growth Trends by Regions
2.2.1 Intra-abdominal Infection Treatment Drugs Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Intra-abdominal Infection Treatment Drugs Historic Market Share by Regions (2016-2021)
2.2.3 Intra-abdominal Infection Treatment Drugs Forecasted Market Size by Regions (2022-2027)
2.3 Intra-abdominal Infection Treatment Drugs Industry Dynamic
2.3.1 Intra-abdominal Infection Treatment Drugs Market Trends
2.3.2 Intra-abdominal Infection Treatment Drugs Market Drivers
2.3.3 Intra-abdominal Infection Treatment Drugs Market Challenges
2.3.4 Intra-abdominal Infection Treatment Drugs Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Intra-abdominal Infection Treatment Drugs Players by Revenue
3.1.1 Global Top Intra-abdominal Infection Treatment Drugs Players by Revenue (2016-2021)
3.1.2 Global Intra-abdominal Infection Treatment Drugs Revenue Market Share by Players (2016-2021)
3.2 Global Intra-abdominal Infection Treatment Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Intra-abdominal Infection Treatment Drugs Revenue
3.4 Global Intra-abdominal Infection Treatment Drugs Market Concentration Ratio
3.4.1 Global Intra-abdominal Infection Treatment Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Intra-abdominal Infection Treatment Drugs Revenue in 2020
3.5 Intra-abdominal Infection Treatment Drugs Key Players Head office and Area Served
3.6 Key Players Intra-abdominal Infection Treatment Drugs Product Solution and Service
3.7 Date of Enter into Intra-abdominal Infection Treatment Drugs Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Intra-abdominal Infection Treatment Drugs Breakdown Data by Type
4.1 Global Intra-abdominal Infection Treatment Drugs Historic Market Size by Type (2016-2021)
4.2 Global Intra-abdominal Infection Treatment Drugs Forecasted Market Size by Type (2022-2027)
5 Intra-abdominal Infection Treatment Drugs Breakdown Data by Application
5.1 Global Intra-abdominal Infection Treatment Drugs Historic Market Size by Application (2016-2021)
5.2 Global Intra-abdominal Infection Treatment Drugs Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Intra-abdominal Infection Treatment Drugs Market Size (2016-2027)
6.2 North America Intra-abdominal Infection Treatment Drugs Market Size by Type
6.2.1 North America Intra-abdominal Infection Treatment Drugs Market Size by Type (2016-2021)
6.2.2 North America Intra-abdominal Infection Treatment Drugs Market Size by Type (2022-2027)
6.2.3 North America Intra-abdominal Infection Treatment Drugs Market Size by Type (2016-2027)
6.3 North America Intra-abdominal Infection Treatment Drugs Market Size by Application
6.3.1 North America Intra-abdominal Infection Treatment Drugs Market Size by Application (2016-2021)
6.3.2 North America Intra-abdominal Infection Treatment Drugs Market Size by Application (2022-2027)
6.3.3 North America Intra-abdominal Infection Treatment Drugs Market Size by Application (2016-2027)
6.4 North America Intra-abdominal Infection Treatment Drugs Market Size by Country
6.4.1 North America Intra-abdominal Infection Treatment Drugs Market Size by Country (2016-2021)
6.4.2 North America Intra-abdominal Infection Treatment Drugs Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Intra-abdominal Infection Treatment Drugs Market Size (2016-2027)
7.2 Europe Intra-abdominal Infection Treatment Drugs Market Size by Type
7.2.1 Europe Intra-abdominal Infection Treatment Drugs Market Size by Type (2016-2021)
7.2.2 Europe Intra-abdominal Infection Treatment Drugs Market Size by Type (2022-2027)
7.2.3 Europe Intra-abdominal Infection Treatment Drugs Market Size by Type (2016-2027)
7.3 Europe Intra-abdominal Infection Treatment Drugs Market Size by Application
7.3.1 Europe Intra-abdominal Infection Treatment Drugs Market Size by Application (2016-2021)
7.3.2 Europe Intra-abdominal Infection Treatment Drugs Market Size by Application (2022-2027)
7.3.3 Europe Intra-abdominal Infection Treatment Drugs Market Size by Application (2016-2027)
7.4 Europe Intra-abdominal Infection Treatment Drugs Market Size by Country
7.4.1 Europe Intra-abdominal Infection Treatment Drugs Market Size by Country (2016-2021)
7.4.2 Europe Intra-abdominal Infection Treatment Drugs Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Intra-abdominal Infection Treatment Drugs Market Size (2016-2027)
8.2 Asia-Pacific Intra-abdominal Infection Treatment Drugs Market Size by Type
8.2.1 Asia-Pacific Intra-abdominal Infection Treatment Drugs Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Intra-abdominal Infection Treatment Drugs Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Intra-abdominal Infection Treatment Drugs Market Size by Type (2016-2027)
8.3 Asia-Pacific Intra-abdominal Infection Treatment Drugs Market Size by Application
8.3.1 Asia-Pacific Intra-abdominal Infection Treatment Drugs Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Intra-abdominal Infection Treatment Drugs Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Intra-abdominal Infection Treatment Drugs Market Size by Application (2016-2027)
8.4 Asia-Pacific Intra-abdominal Infection Treatment Drugs Market Size by Region
8.4.1 Asia-Pacific Intra-abdominal Infection Treatment Drugs Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Intra-abdominal Infection Treatment Drugs Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Intra-abdominal Infection Treatment Drugs Market Size (2016-2027)
9.2 Latin America Intra-abdominal Infection Treatment Drugs Market Size by Type
9.2.1 Latin America Intra-abdominal Infection Treatment Drugs Market Size by Type (2016-2021)
9.2.2 Latin America Intra-abdominal Infection Treatment Drugs Market Size by Type (2022-2027)
9.2.3 Latin America Intra-abdominal Infection Treatment Drugs Market Size by Type (2016-2027)
9.3 Latin America Intra-abdominal Infection Treatment Drugs Market Size by Application
9.3.1 Latin America Intra-abdominal Infection Treatment Drugs Market Size by Application (2016-2021)
9.3.2 Latin America Intra-abdominal Infection Treatment Drugs Market Size by Application (2022-2027)
9.3.3 Latin America Intra-abdominal Infection Treatment Drugs Market Size by Application (2016-2027)
9.4 Latin America Intra-abdominal Infection Treatment Drugs Market Size by Country
9.4.1 Latin America Intra-abdominal Infection Treatment Drugs Market Size by Country (2016-2021)
9.4.2 Latin America Intra-abdominal Infection Treatment Drugs Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Intra-abdominal Infection Treatment Drugs Market Size (2016-2027)
10.2 Middle East & Africa Intra-abdominal Infection Treatment Drugs Market Size by Type
10.2.1 Middle East & Africa Intra-abdominal Infection Treatment Drugs Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Intra-abdominal Infection Treatment Drugs Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Intra-abdominal Infection Treatment Drugs Market Size by Type (2016-2027)
10.3 Middle East & Africa Intra-abdominal Infection Treatment Drugs Market Size by Application
10.3.1 Middle East & Africa Intra-abdominal Infection Treatment Drugs Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Intra-abdominal Infection Treatment Drugs Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Intra-abdominal Infection Treatment Drugs Market Size by Application (2016-2027)
10.4 Middle East & Africa Intra-abdominal Infection Treatment Drugs Market Size by Country
10.4.1 Middle East & Africa Intra-abdominal Infection Treatment Drugs Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Intra-abdominal Infection Treatment Drugs Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 AstraZeneca
11.1.1 AstraZeneca Company Details
11.1.2 AstraZeneca Business Overview
11.1.3 AstraZeneca Intra-abdominal Infection Treatment Drugs Introduction
11.1.4 AstraZeneca Revenue in Intra-abdominal Infection Treatment Drugs Business (2016-2021)
11.1.5 AstraZeneca Recent Development
11.2 Merck
11.2.1 Merck Company Details
11.2.2 Merck Business Overview
11.2.3 Merck Intra-abdominal Infection Treatment Drugs Introduction
11.2.4 Merck Revenue in Intra-abdominal Infection Treatment Drugs Business (2016-2021)
11.2.5 Merck Recent Development
11.3 Pfizer
11.3.1 Pfizer Company Details
11.3.2 Pfizer Business Overview
11.3.3 Pfizer Intra-abdominal Infection Treatment Drugs Introduction
11.3.4 Pfizer Revenue in Intra-abdominal Infection Treatment Drugs Business (2016-2021)
11.3.5 Pfizer Recent Development
11.4 AtoxBio
11.4.1 AtoxBio Company Details
11.4.2 AtoxBio Business Overview
11.4.3 AtoxBio Intra-abdominal Infection Treatment Drugs Introduction
11.4.4 AtoxBio Revenue in Intra-abdominal Infection Treatment Drugs Business (2016-2021)
11.4.5 AtoxBio Recent Development
11.5 Dainippon Sumitomo Pharma
11.5.1 Dainippon Sumitomo Pharma Company Details
11.5.2 Dainippon Sumitomo Pharma Business Overview
11.5.3 Dainippon Sumitomo Pharma Intra-abdominal Infection Treatment Drugs Introduction
11.5.4 Dainippon Sumitomo Pharma Revenue in Intra-abdominal Infection Treatment Drugs Business (2016-2021)
11.5.5 Dainippon Sumitomo Pharma Recent Development
11.6 Bayer
11.6.1 Bayer Company Details
11.6.2 Bayer Business Overview
11.6.3 Bayer Intra-abdominal Infection Treatment Drugs Introduction
11.6.4 Bayer Revenue in Intra-abdominal Infection Treatment Drugs Business (2016-2021)
11.6.5 Bayer Recent Development
11.7 Bristol-Myers Squibb
11.7.1 Bristol-Myers Squibb Company Details
11.7.2 Bristol-Myers Squibb Business Overview
11.7.3 Bristol-Myers Squibb Intra-abdominal Infection Treatment Drugs Introduction
11.7.4 Bristol-Myers Squibb Revenue in Intra-abdominal Infection Treatment Drugs Business (2016-2021)
11.7.5 Bristol-Myers Squibb Recent Development
11.8 Mylan Pharmaceuticals Inc.
11.8.1 Mylan Pharmaceuticals Inc. Company Details
11.8.2 Mylan Pharmaceuticals Inc. Business Overview
11.8.3 Mylan Pharmaceuticals Inc. Intra-abdominal Infection Treatment Drugs Introduction
11.8.4 Mylan Pharmaceuticals Inc. Revenue in Intra-abdominal Infection Treatment Drugs Business (2016-2021)
11.8.5 Mylan Pharmaceuticals Inc. Recent Development
11.9 Sun Pharmaceutical Industries, Inc.
11.9.1 Sun Pharmaceutical Industries, Inc. Company Details
11.9.2 Sun Pharmaceutical Industries, Inc. Business Overview
11.9.3 Sun Pharmaceutical Industries, Inc. Intra-abdominal Infection Treatment Drugs Introduction
11.9.4 Sun Pharmaceutical Industries, Inc. Revenue in Intra-abdominal Infection Treatment Drugs Business (2016-2021)
11.9.5 Sun Pharmaceutical Industries, Inc. Recent Development
11.10 Teva Pharmaceutical Industries
11.10.1 Teva Pharmaceutical Industries Company Details
11.10.2 Teva Pharmaceutical Industries Business Overview
11.10.3 Teva Pharmaceutical Industries Intra-abdominal Infection Treatment Drugs Introduction
11.10.4 Teva Pharmaceutical Industries Revenue in Intra-abdominal Infection Treatment Drugs Business (2016-2021)
11.10.5 Teva Pharmaceutical Industries Recent Development
11.11 Dr. Reddy’s Laboratories
11.11.1 Dr. Reddy’s Laboratories Company Details
11.11.2 Dr. Reddy’s Laboratories Business Overview
11.11.3 Dr. Reddy’s Laboratories Intra-abdominal Infection Treatment Drugs Introduction
11.11.4 Dr. Reddy’s Laboratories Revenue in Intra-abdominal Infection Treatment Drugs Business (2016-2021)
11.11.5 Dr. Reddy’s Laboratories Recent Development
11.12 Roche Holding AG
11.12.1 Roche Holding AG Company Details
11.12.2 Roche Holding AG Business Overview
11.12.3 Roche Holding AG Intra-abdominal Infection Treatment Drugs Introduction
11.12.4 Roche Holding AG Revenue in Intra-abdominal Infection Treatment Drugs Business (2016-2021)
11.12.5 Roche Holding AG Recent Development
11.13 GlaxoSmithKline
11.13.1 GlaxoSmithKline Company Details
11.13.2 GlaxoSmithKline Business Overview
11.13.3 GlaxoSmithKline Intra-abdominal Infection Treatment Drugs Introduction
11.13.4 GlaxoSmithKline Revenue in Intra-abdominal Infection Treatment Drugs Business (2016-2021)
11.13.5 GlaxoSmithKline Recent Development
11.14 Sanofi
11.14.1 Sanofi Company Details
11.14.2 Sanofi Business Overview
11.14.3 Sanofi Intra-abdominal Infection Treatment Drugs Introduction
11.14.4 Sanofi Revenue in Intra-abdominal Infection Treatment Drugs Business (2016-2021)
11.14.5 Sanofi Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Intra-abdominal Infection Treatment Drugs Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Chloramphenicol
Table 3. Key Players of Beta Lactums
Table 4. Key Players of Quinolones
Table 5. Key Players of Aminoglycosides
Table 6. Key Players of Others
Table 7. Global Intra-abdominal Infection Treatment Drugs Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Intra-abdominal Infection Treatment Drugs Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 9. Global Intra-abdominal Infection Treatment Drugs Market Size by Regions (2016-2021) & (US$ Million)
Table 10. Global Intra-abdominal Infection Treatment Drugs Market Share by Regions (2016-2021)
Table 11. Global Intra-abdominal Infection Treatment Drugs Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 12. Global Intra-abdominal Infection Treatment Drugs Market Share by Regions (2022-2027)
Table 13. Intra-abdominal Infection Treatment Drugs Market Trends
Table 14. Intra-abdominal Infection Treatment Drugs Market Drivers
Table 15. Intra-abdominal Infection Treatment Drugs Market Challenges
Table 16. Intra-abdominal Infection Treatment Drugs Market Restraints
Table 17. Global Intra-abdominal Infection Treatment Drugs Revenue by Players (2016-2021) & (US$ Million)
Table 18. Global Intra-abdominal Infection Treatment Drugs Market Share by Players (2016-2021)
Table 19. Global Top Intra-abdominal Infection Treatment Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Intra-abdominal Infection Treatment Drugs as of 2020)
Table 20. Ranking of Global Top Intra-abdominal Infection Treatment Drugs Companies by Revenue (US$ Million) in 2020
Table 21. Global 5 Largest Players Market Share by Intra-abdominal Infection Treatment Drugs Revenue (CR5 and HHI) & (2016-2021)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Intra-abdominal Infection Treatment Drugs Product Solution and Service
Table 24. Date of Enter into Intra-abdominal Infection Treatment Drugs Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Intra-abdominal Infection Treatment Drugs Market Size by Type (2016-2021) (US$ Million)
Table 27. Global Intra-abdominal Infection Treatment Drugs Revenue Market Share by Type (2016-2021)
Table 28. Global Intra-abdominal Infection Treatment Drugs Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 29. Global Intra-abdominal Infection Treatment Drugs Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 30. Global Intra-abdominal Infection Treatment Drugs Market Size Share by Application (2016-2021) & (US$ Million)
Table 31. Global Intra-abdominal Infection Treatment Drugs Revenue Market Share by Application (2016-2021)
Table 32. Global Intra-abdominal Infection Treatment Drugs Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 33. Global Intra-abdominal Infection Treatment Drugs Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 34. North America Intra-abdominal Infection Treatment Drugs Market Size by Type (2016-2021) (US$ Million)
Table 35. North America Intra-abdominal Infection Treatment Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 36. North America Intra-abdominal Infection Treatment Drugs Market Size by Application (2016-2021) (US$ Million)
Table 37. North America Intra-abdominal Infection Treatment Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 38. North America Intra-abdominal Infection Treatment Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 39. North America Intra-abdominal Infection Treatment Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 40. Europe Intra-abdominal Infection Treatment Drugs Market Size by Type (2016-2021) (US$ Million)
Table 41. Europe Intra-abdominal Infection Treatment Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 42. Europe Intra-abdominal Infection Treatment Drugs Market Size by Application (2016-2021) (US$ Million)
Table 43. Europe Intra-abdominal Infection Treatment Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 44. Europe Intra-abdominal Infection Treatment Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 45. Europe Intra-abdominal Infection Treatment Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Intra-abdominal Infection Treatment Drugs Market Size by Type (2016-2021) (US$ Million)
Table 47. Asia-Pacific Intra-abdominal Infection Treatment Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Intra-abdominal Infection Treatment Drugs Market Size by Application (2016-2021) (US$ Million)
Table 49. Asia-Pacific Intra-abdominal Infection Treatment Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 50. Asia-Pacific Intra-abdominal Infection Treatment Drugs Market Size by Region (2016-2021) & (US$ Million)
Table 51. Asia-Pacific Intra-abdominal Infection Treatment Drugs Market Size by Region (2022-2027) & (US$ Million)
Table 52. Latin America Intra-abdominal Infection Treatment Drugs Market Size by Type (2016-2021) (US$ Million)
Table 53. Latin America Intra-abdominal Infection Treatment Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 54. Latin America Intra-abdominal Infection Treatment Drugs Market Size by Application (2016-2021) (US$ Million)
Table 55. Latin America Intra-abdominal Infection Treatment Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 56. Latin America Intra-abdominal Infection Treatment Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 57. Latin America Intra-abdominal Infection Treatment Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Intra-abdominal Infection Treatment Drugs Market Size by Type (2016-2021) (US$ Million)
Table 59. Middle East & Africa Intra-abdominal Infection Treatment Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Intra-abdominal Infection Treatment Drugs Market Size by Application (2016-2021) (US$ Million)
Table 61. Middle East & Africa Intra-abdominal Infection Treatment Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 62. Middle East & Africa Intra-abdominal Infection Treatment Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 63. Middle East & Africa Intra-abdominal Infection Treatment Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 64. AstraZeneca Company Details
Table 65. AstraZeneca Business Overview
Table 66. AstraZeneca Intra-abdominal Infection Treatment Drugs Product
Table 67. AstraZeneca Revenue in Intra-abdominal Infection Treatment Drugs Business (2016-2021) & (US$ Million)
Table 68. AstraZeneca Recent Development
Table 69. Merck Company Details
Table 70. Merck Business Overview
Table 71. Merck Intra-abdominal Infection Treatment Drugs Product
Table 72. Merck Revenue in Intra-abdominal Infection Treatment Drugs Business (2016-2021) & (US$ Million)
Table 73. Merck Recent Development
Table 74. Pfizer Company Details
Table 75. Pfizer Business Overview
Table 76. Pfizer Intra-abdominal Infection Treatment Drugs Product
Table 77. Pfizer Revenue in Intra-abdominal Infection Treatment Drugs Business (2016-2021) & (US$ Million)
Table 78. Pfizer Recent Development
Table 79. AtoxBio Company Details
Table 80. AtoxBio Business Overview
Table 81. AtoxBio Intra-abdominal Infection Treatment Drugs Product
Table 82. AtoxBio Revenue in Intra-abdominal Infection Treatment Drugs Business (2016-2021) & (US$ Million)
Table 83. AtoxBio Recent Development
Table 84. Dainippon Sumitomo Pharma Company Details
Table 85. Dainippon Sumitomo Pharma Business Overview
Table 86. Dainippon Sumitomo Pharma Intra-abdominal Infection Treatment Drugs Product
Table 87. Dainippon Sumitomo Pharma Revenue in Intra-abdominal Infection Treatment Drugs Business (2016-2021) & (US$ Million)
Table 88. Dainippon Sumitomo Pharma Recent Development
Table 89. Bayer Company Details
Table 90. Bayer Business Overview
Table 91. Bayer Intra-abdominal Infection Treatment Drugs Product
Table 92. Bayer Revenue in Intra-abdominal Infection Treatment Drugs Business (2016-2021) & (US$ Million)
Table 93. Bayer Recent Development
Table 94. Bristol-Myers Squibb Company Details
Table 95. Bristol-Myers Squibb Business Overview
Table 96. Bristol-Myers Squibb Intra-abdominal Infection Treatment Drugs Product
Table 97. Bristol-Myers Squibb Revenue in Intra-abdominal Infection Treatment Drugs Business (2016-2021) & (US$ Million)
Table 98. Bristol-Myers Squibb Recent Development
Table 99. Mylan Pharmaceuticals Inc. Company Details
Table 100. Mylan Pharmaceuticals Inc. Business Overview
Table 101. Mylan Pharmaceuticals Inc. Revenue in Intra-abdominal Infection Treatment Drugs Business (2016-2021) & (US$ Million)
Table 102. Mylan Pharmaceuticals Inc. Recent Development
Table 103. Sun Pharmaceutical Industries, Inc. Company Details
Table 104. Sun Pharmaceutical Industries, Inc. Business Overview
Table 105. Sun Pharmaceutical Industries, Inc. Intra-abdominal Infection Treatment Drugs Product
Table 106. Sun Pharmaceutical Industries, Inc. Revenue in Intra-abdominal Infection Treatment Drugs Business (2016-2021) & (US$ Million)
Table 107. Sun Pharmaceutical Industries, Inc. Recent Development
Table 108. Teva Pharmaceutical Industries Company Details
Table 109. Teva Pharmaceutical Industries Business Overview
Table 110. Teva Pharmaceutical Industries Intra-abdominal Infection Treatment Drugs Product
Table 111. Teva Pharmaceutical Industries Revenue in Intra-abdominal Infection Treatment Drugs Business (2016-2021) & (US$ Million)
Table 112. Teva Pharmaceutical Industries Recent Development
Table 113. Dr. Reddy’s Laboratories Company Details
Table 114. Dr. Reddy’s Laboratories Business Overview
Table 115. Dr. Reddy’s Laboratories Intra-abdominal Infection Treatment Drugs Product
Table 116. Dr. Reddy’s Laboratories Revenue in Intra-abdominal Infection Treatment Drugs Business (2016-2021) & (US$ Million)
Table 117. Dr. Reddy’s Laboratories Recent Development
Table 118. Roche Holding AG Company Details
Table 119. Roche Holding AG Business Overview
Table 120. Roche Holding AG Intra-abdominal Infection Treatment Drugs Product
Table 121. Roche Holding AG Revenue in Intra-abdominal Infection Treatment Drugs Business (2016-2021) & (US$ Million)
Table 122. Roche Holding AG Recent Development
Table 123. GlaxoSmithKline Company Details
Table 124. GlaxoSmithKline Business Overview
Table 125. GlaxoSmithKline Intra-abdominal Infection Treatment Drugs Product
Table 126. GlaxoSmithKline Revenue in Intra-abdominal Infection Treatment Drugs Business (2016-2021) & (US$ Million)
Table 127. GlaxoSmithKline Recent Development
Table 128. Sanofi Company Details
Table 129. Sanofi Business Overview
Table 130. Sanofi Intra-abdominal Infection Treatment Drugs Product
Table 131. Sanofi Revenue in Intra-abdominal Infection Treatment Drugs Business (2016-2021) & (US$ Million)
Table 132. Sanofi Recent Development
Table 133. Research Programs/Design for This Report
Table 134. Key Data Information from Secondary Sources
Table 135. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Intra-abdominal Infection Treatment Drugs Market Share by Type: 2020 VS 2027
Figure 2. Chloramphenicol Features
Figure 3. Beta Lactums Features
Figure 4. Quinolones Features
Figure 5. Aminoglycosides Features
Figure 6. Others Features
Figure 7. Global Intra-abdominal Infection Treatment Drugs Market Share by Application: 2020 VS 2027
Figure 8. Intra-abdominal Abscess Case Studies
Figure 9. Appendicitis Case Studies
Figure 10. Diverticulitis Case Studies
Figure 11. Diarrhea Case Studies
Figure 12. Food Poisoning Case Studies
Figure 13. Infection by Helicobacter Pylori Case Studies
Figure 14. Intra-abdominal Infection Treatment Drugs Report Years Considered
Figure 15. Global Intra-abdominal Infection Treatment Drugs Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 16. Global Intra-abdominal Infection Treatment Drugs Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 17. Global Intra-abdominal Infection Treatment Drugs Market Share by Regions: 2020 VS 2027
Figure 18. Global Intra-abdominal Infection Treatment Drugs Market Share by Regions (2022-2027)
Figure 19. Global Intra-abdominal Infection Treatment Drugs Market Share by Players in 2020
Figure 20. Global Top Intra-abdominal Infection Treatment Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Intra-abdominal Infection Treatment Drugs as of 2020
Figure 21. The Top 10 and 5 Players Market Share by Intra-abdominal Infection Treatment Drugs Revenue in 2020
Figure 22. Global Intra-abdominal Infection Treatment Drugs Revenue Market Share by Type (2016-2021)
Figure 23. Global Intra-abdominal Infection Treatment Drugs Revenue Market Share by Type (2022-2027)
Figure 24. North America Intra-abdominal Infection Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. North America Intra-abdominal Infection Treatment Drugs Market Share by Type (2016-2027)
Figure 26. North America Intra-abdominal Infection Treatment Drugs Market Share by Application (2016-2027)
Figure 27. North America Intra-abdominal Infection Treatment Drugs Market Share by Country (2016-2027)
Figure 28. United States Intra-abdominal Infection Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. Canada Intra-abdominal Infection Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. Europe Intra-abdominal Infection Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Europe Intra-abdominal Infection Treatment Drugs Market Share by Type (2016-2027)
Figure 32. Europe Intra-abdominal Infection Treatment Drugs Market Share by Application (2016-2027)
Figure 33. Europe Intra-abdominal Infection Treatment Drugs Market Share by Country (2016-2027)
Figure 34. Germany Intra-abdominal Infection Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. France Intra-abdominal Infection Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. U.K. Intra-abdominal Infection Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Italy Intra-abdominal Infection Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Russia Intra-abdominal Infection Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Nordic Intra-abdominal Infection Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Asia-Pacific Intra-abdominal Infection Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Asia-Pacific Intra-abdominal Infection Treatment Drugs Market Share by Type (2016-2027)
Figure 42. Asia-Pacific Intra-abdominal Infection Treatment Drugs Market Share by Application (2016-2027)
Figure 43. Asia-Pacific Intra-abdominal Infection Treatment Drugs Market Share by Region (2016-2027)
Figure 44. China Intra-abdominal Infection Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Japan Intra-abdominal Infection Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. South Korea Intra-abdominal Infection Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Southeast Asia Intra-abdominal Infection Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. India Intra-abdominal Infection Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Australia Intra-abdominal Infection Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Latin America Intra-abdominal Infection Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Latin America Intra-abdominal Infection Treatment Drugs Market Share by Type (2016-2027)
Figure 52. Latin America Intra-abdominal Infection Treatment Drugs Market Share by Application (2016-2027)
Figure 53. Latin America Intra-abdominal Infection Treatment Drugs Market Share by Country (2016-2027)
Figure 54. Mexico Intra-abdominal Infection Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Brazil Intra-abdominal Infection Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Middle East & Africa Intra-abdominal Infection Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Middle East & Africa Intra-abdominal Infection Treatment Drugs Market Share by Type (2016-2027)
Figure 58. Middle East & Africa Intra-abdominal Infection Treatment Drugs Market Share by Application (2016-2027)
Figure 59. Middle East & Africa Intra-abdominal Infection Treatment Drugs Market Share by Country (2016-2027)
Figure 60. Turkey Intra-abdominal Infection Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 61. Saudi Arabia Intra-abdominal Infection Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 62. UAE Intra-abdominal Infection Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 63. AstraZeneca Revenue Growth Rate in Intra-abdominal Infection Treatment Drugs Business (2016-2021)
Figure 64. Merck Revenue Growth Rate in Intra-abdominal Infection Treatment Drugs Business (2016-2021)
Figure 65. Pfizer Revenue Growth Rate in Intra-abdominal Infection Treatment Drugs Business (2016-2021)
Figure 66. AtoxBio Revenue Growth Rate in Intra-abdominal Infection Treatment Drugs Business (2016-2021)
Figure 67. Dainippon Sumitomo Pharma Revenue Growth Rate in Intra-abdominal Infection Treatment Drugs Business (2016-2021)
Figure 68. Bayer Revenue Growth Rate in Intra-abdominal Infection Treatment Drugs Business (2016-2021)
Figure 69. Bristol-Myers Squibb Revenue Growth Rate in Intra-abdominal Infection Treatment Drugs Business (2016-2021)
Figure 70. Mylan Pharmaceuticals Inc. Revenue Growth Rate in Intra-abdominal Infection Treatment Drugs Business (2016-2021)
Figure 71. Sun Pharmaceutical Industries, Inc. Revenue Growth Rate in Intra-abdominal Infection Treatment Drugs Business (2016-2021)
Figure 72. Teva Pharmaceutical Industries Revenue Growth Rate in Intra-abdominal Infection Treatment Drugs Business (2016-2021)
Figure 73. Dr. Reddy’s Laboratories Revenue Growth Rate in Intra-abdominal Infection Treatment Drugs Business (2016-2021)
Figure 74. Roche Holding AG Revenue Growth Rate in Intra-abdominal Infection Treatment Drugs Business (2016-2021)
Figure 75. GlaxoSmithKline Revenue Growth Rate in Intra-abdominal Infection Treatment Drugs Business (2016-2021)
Figure 76. Sanofi Revenue Growth Rate in Intra-abdominal Infection Treatment Drugs Business (2016-2021)
Figure 77. Bottom-up and Top-down Approaches for This Report
Figure 78. Data Triangulation
Figure 79. Key Executives Interviewed
世界の羊膜感染症治療市場規模・現状・予測（2021年-2027年） Intra-amniotic infection is a common occurrence in pregnant women, which affects both the mother and baby. Intra-amniotic infection is also known as chorioamnionitis. The incidence is high at lower gestational ages. Market Analysis and Insights: Global Intra-amniotic Infection Treatment Market The …- 世界の腹腔内手術用イメージング市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Abdominal Cavity Surgical Imaging Market The global Abdominal Cavity Surgical Imaging market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high da…
- 大動脈内バルーンポンプ(IABP)のグローバル市場2021 The IABP is an electromechanical system used to inflate and deflate an intra-aortic balloon to provide temporary support to the left ventricle via the principle of counter pulsation. Intra-aortic balloon pump (IABP) is a cardiovascular medical device for temporarily improving cardiac function in hum…
- 世界の上気道感染症治療市場規模・現状・予測（2021年-2027年） Rhinitis, sinusitis, nasopharyngitis, epiglottitis, laryngitis, and whooping cough are some of the types of upper respiratory tract infections. It can be treated with various drugs such as azithromycin, doxycycline, xylometazoline, propylhexedrine, amoxicillin, clarithromycin, aspirin, ibuprofen, er…
- 世界のボツリヌス菌感染症治療市場規模・現状・予測（2021年-2027年） Clostridium botulinum infections are caused by clostridium botulinum, a gram-positive, rod-shaped bacterium which produces an extremely lethal substance that is botulism neurotoxin. Market Analysis and Insights: Global Clostridium Botulinum Infection Treatment Market The global Clostridium Botulinum…